Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02464228
Title Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kura Oncology, Inc.
Indications

anaplastic large cell lymphoma

peripheral T-cell lymphoma

Therapies

Tipifarnib

Age Groups: adult
Covered Countries USA


No variant requirements are available.